NLK and non-small cell lung carcinoma: Data in vitro and in vivo in non-small-cell lung cancer (NSCLC) cell lines showed that the biguanide—via inhibition of NLK expression—induced cell cycle arrest and significant reduction of the stem cell tumor population [94].